Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Aralık 2025 | 0 |
| Ocak 2026 | 0 |
| Şubat 2026 | 0 |
| Mart 2026 | 0 |
| Nisan 2026 | 0 |
| Mayıs 2026 | 0 |
| Haziran 2026 | 0 |
